EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report

Aye Nyein Thu, Munir Babar

Cureus · 28.06.2026

DOI: 10.7759/cureus.111692 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 28.06.2026. Verfasst von Aye Nyein Thu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology, Worcestershire Acute Hospitals NHS Trust, Worcester, GBR. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

autoimmune hypophysitishypogonadotrophic hypogonadismhypopituitarismimmune checkpoint inhibitors (icis)immune-related adverse events (iraes)melanomapd-1 inhibitorpembrolizumabpembrolizumab-induced hypophysitissecondary adrenal insufficiency

Autor:innen und Institutionen

  • Diabetes and Endocrinology, Worcestershire Acute Hospitals NHS Trust, Worcester, GBR.

Zitieren

APA

Thu, A. N., & Babar, M. (2026). Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report. Cureus. https://doi.org/10.7759/cureus.111692

Vancouver

Thu AN, Babar M. Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report. Cureus. 2026. doi:10.7759/cureus.111692

BibTeX
@article{Thu2026,
  author = {Thu, Aye Nyein and Babar, Munir},
  title = {Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.111692}
}
Kostenlos starten →